Researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other for diagnosed patients who do not require a hospital stay.
It is startling to see the words “now in the third year of the pandemic” in print, but here we are.
The CDC has switched from talking about being “fully vaccinated” to staying “up to date on vaccinations.”
President Gabel announced some drop in the mask policy on UMN Twin Cities campus. But does that mean we're out of the clear?